Whilst APC mutations give rise to truncated proteins, particularly in CRC, CTNNB1-activating mutations give rise to stabilized β-catenin through point mutations in HCC, endometrial cancer, and pancreatic cancer. Here, CTNNB1 is linked to endometrial cancer.